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Edited by Vladimir SkulachevAbstract Tea-catechin derivatives are shown to inhibit activi-
ties of caspases-3, 2 and 7 in vitro, and prevented experimental
apoptosis at the cell and animal levels. Epigallo-catechin-gallate
showed the strongest inhibition at 1 · 107 M to these caspases,
but cysteine cathepsins and caspase-8 were not inhibited. Cas-
pase-3 inhibition showed a 2nd-order allosteric-type, but the inhi-
bition of caspases-2 and 7 showed a non-competitive-type. The
apoptosis-test using cultured HeLa cells was inhibited by these
catechins. In rat hepatocytes, apoptosis was induced by D-galac-
tosamine in vivo. In this case, caspase-3 activity in the cyto-
plasm, the serum aminotransferases and dUTP nick formation
detected by TUNNEL-staining were eﬀects, and these elevations
were suppressed by administration of catechin.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Various pharmacological functions of tea-catechin deriva-
tives have been extensively studied in recent years. Their
anti-oxidant eﬀects are well established; in addition, the possi-
bility for prevention of oncogenesis by tea-catechins from the
aspect of epidemiological statistics has been advocated. How-
ever, no reasonable explanation exists for the prevention of
oncogenesis at the molecular level (see Section 4). The direct
eﬀect of tea-catechins on speciﬁc caspases with respect to
apoptosis has not yet been reported. The synthetic inhibitors
of substrate analogues for caspases have been reported; how-
ever, natural inhibitors have not been identiﬁed. Allosteric
inhibition of caspase-3 by synthetic inhibitors was reportedAbbreviations: AST, aspartate aminotransferase; ALT, alanine ami-
notransferase; EGCG, epigallo-catechin gallate; ECG, epi-catechin
gallate; CG, catechin gallate; EC, epi-catechin; EGC, epigallo-catechin;
C, catechin; GC, gallo-catechin; G, gallate; LPS, lipopolysaccharide;
TdT, terminal transferase; MCA, methyl coumaryl amide
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doi:10.1016/j.febslet.2005.12.087by Hardy et al., therefore the tertiary structures of caspases
are ﬂexible (see Section 4) [11]. We have previously shown that
some tea-catechin derivatives strongly inhibited caspases-3, 2
and 7, in vitro and in vivo [1,2,5–9].
The inhibition of cultured HeLa cell apoptosis test, which is
reported by Wells et al., was studied [4]. Liver injury induced
by D-galactosamine with lipopolysaccharide (LPS) in vivo is
well characterized to induce hepatocyte apoptosis within the
pathological ﬁeld, assessed by TUNNEL-staining and DNA
fragmentation [1–4]. The activity of caspase-3 in the liver cyto-
plasm was signiﬁcantly elevated, and aspartate (AST) and ala-
nine (ALT) aminotransferases in the serum were also
signiﬁcantly elevated in the D-galactosamine induced apoptotic
liver. These increases were suppressed by epigallo-catechin-gal-
late (EGCG) in vivo. EGCG is the main component of green
tea. The speciﬁc inhibition of activities of caspases-3, 2 and 7
by tea-catechin derivatives in vitro and the prevention of liver
cell apoptosis in vivo are reported in this paper.2. Materials and methods
2.1. Materials
Recombinant human caspases-3, 7, 8 and 2 were purchased from
Bio-Vision Co. Catechin derivatives were purchased from Wako Co.
Cathepsin B and L were purchased from Sigma.
2.2. Methods
2.2.1. Inhibition assays of caspases-3, 7, 2 and 8 activities by catechin
derivatives. An established method for the assay of activities of cas-
pase-3 and caspase-7 was used [9], using the recombinant pure caspases
and DEVD-AFC as the substrate. Ac-IETD-MCA was used for cas-
pase-8 and AC-VDVAD-MCA was used for caspase-2. Enzyme activ-
ity was expressed as the released AFC (or MCA) formed nM/h/mg
protein.
2.2.2. Cell-free apoptosis test using cultured HeLa cell S-100. The
apoptosis assay system reported by Wells et al. is composed of cultured
HeLa cell cytoplasm S-100 (4 mg protein/ml), cytochrome c (80 lM)
and Ac-DEVD-MCA (40 lM) as the substrate for formed caspase-3
[12]. Preparation of S-100 from cultured HeLa cells was followed using
the method described by Wells and Nguyen [12]. Following incubation
at 37 C for 40 min, the released ﬂuorescent MCA in the S-100 fraction
was assayed as formed caspase-3 from procaspase-3 in the S-100. Cas-
pase-3 activity without addition of cytochrome c was used as the neg-
ative control.
2.2.3. Administration method of D-galactosamine and tea-catechin
derivatives in rats. Liver apoptosis was induced according to Mun-
tane’s method, by intraperitoneal injection of D-galactosamine [3,4].
A single dose of D-galactosamine was administered intraperitoneallyblished by Elsevier B.V. All rights reserved.
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of EGCG with 50 lg/kg of LPS were administered intraperitoneally at
1 h before and after the D-galactosamine administration. EGCG was
further administered twice at 3-h intervals.
2.2.4. Preparation of liver cytoplasm for assay of caspase-3 activ-
ity. Liver cytoplasm fraction for caspase-3 activity assay was pre-
pared by sequential centrifugation method for cell organelle
separation according to a method described by Fleisher and Kervina
[16].
2.2.5. TdT-mediated dUTP nick end labeling (TUNNEL)
assay. Apoptotic cells were detected in sections using the in situ
Apoptosis Kit (Takara Kyoto, Japan). Frozen sections of liver tissues
were ﬁxed in 3% paraformaldehyde, incubated with protease K (20 lg/
ml) for 10 min, and then presoaked in terminal transferase (TdT) buf-
fer (0.5 lM/L cacodylate, 1 lM/L CoCl, 0.5 lM/L dithiothreitol,
0.05% bovine serum albumin, and 0.15 M/L NaCl) for 10 min. Sec-
tions were incubated for 1 h at 37 C in 25 ml of TdT solution, contain-Table 1
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TdT. After the TdT reaction, sections were soaked in TdT blocking
buﬀer (300 nM/L NaCl and 30 mM/L tri-sodium citrate-2-hydrate),
incubated with HRP-conjugated streptavidin for 30 min at room tem-
perature, and developed for 10 min in phosphate-buﬀered citrate (pH
5.8) containing 0.6 mg/ml DAB. Nuclei were counterstained with
hematoxylin.3. Results
3.1. Inhibition of caspase-3 activity by various catechin
derivatives in vitro
Caspase-3 plays a central role as an executive enzyme of apop-
tosis in the ﬁnal step of various apoptotic cascades [5–9].t using cultured HeLa cells by tea-catechin derivatives
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1 · 107 M and was inhibited to 50% at 1 · 108 M in vitro.
Epi-catechin gallate (ECG) showed 50% inhibition at
1 · 107M, and catechin gallate (CG), epi-catechin (EC) and
epigallo-catechin (EGC) had induced inhibition at 1 · 106 M.
Catechin (C), gallo-catechin (GC) and gallate (G) showed no
inhibition as Table 1 shows. The stereo-binding form of –OH
to the catechin-ring should be an epi-structure to display inhib-
itory activity. Thepresence of either component, catechin gallate
(CG) and/or epi-form catechin (EC), is essential.
Relationship of velocity and substrate concentration of cas-
pase-3 in the presence of EGCG showed a typical sigmoidal
curve and the Lineweaver–Burk relationship did not give a
straight line, but showed a logarithmic curve. When the abscis-
sa was taken as 1/[S]2, the logarithmic curve changed to a
straight line (Fig. 1A). The inhibition kinetics of these catechin
derivatives appear to be a 2nd-order sigmoidal allosteric inhi-
bition as follows:
1=v ¼ Km=V ð1=½S2Þ þ 1=V .
The other four eﬀective catechin derivatives, such as
ECG, CG, EC and EGC, also showed the same type of allo-
steric inhibition to caspase-3 as that by EGCG (ﬁgures are
abbreviated).
The binding site of the catechins appeared to be diﬀerent
from the substrate-binding site. The allosteric nature of cas-
pase-3 using synthetic inhibitors was reported by Hardy
et al. [11] (see Section 4). The molecular weight of caspase-3
did not appear to change in the presence of EGCG and/or sub-
strate using Superdex G-75. Therefore, polymerization or
depolymerization was not observed using these allosteric
inhibitors (data not shown).0
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C3.2. Inhibitions of activities of caspases-7 and 2 activities by
EGCG in vitro
Caspases-7 and 2 are also known to participate in various
apoptosis cascades. The activities of caspases-7 and 2 were also
strongly inhibited by EGCG, and the 50% activities were inhib-
ited at 1 · 106 M. However, the mode of inhibitions of casp-
ases-7 and 2 were diﬀerent from that of caspase-3. The Vmax
decreased in the presence of EGCG and the Lineweaver–Burk
relationship showed a non-competitive type inhibition (Fig. 1B
and C). The binding site to EGCG is the same as the sub-
strate-binding site or located near the active site. Caspase-8,
cathepsins B and L, which are the same cysteine proteases, were
not inhibited at 1 · 105 MofEGCG.Therefore, the inhibitions
of caspases are not due to an attack to the active site –SHof these
enzymes by the scavenger eﬀect of catechins.Fig. 1. Mode of inhibitions of caspase-3, 2 and 7 by EGCG in
Lineweaver–Burk relationship. (A) Caspase-3 inhibition by
1 · 107 M of EGCG. The 1/v values to the 1/[S] in the presence
of EGCG are expressed as open circles with a thin solid line (s–s).
The 1/v values to the 1/[S] in the absence of EGCG are illustrated as
closed squares with a solid line. The 1/v values to the 1/[S]2
illustration in the presence of EGCG are expressed as open circles
with a broken line (s- - -s). (B) and (C) Caspase-2 or 7 inhibition
by 1 · 106 M of EGCG. The activities in the absence of EGCG are
illustrated as solid line with a solid line and the activities in the
presence of EGCG are illustrated as open circles with a broken line.
(B) shows caspase-2 inhibition by EGCG; the Lineweaver–Burk
relationship. (C) shows caspase-7 inhibition by EGCG. All symbols
and lines are the same as those in (B).3.3. Inhibition of caspase-3 in HeLa cell apoptosis test induced
by cytochrome c by EGCG
Wells et al. developed a cell-free apoptosis test using cul-
tured HeLa cells [12]. The S-100 prepared from cultured HeLa
cell cytoplasm contains suﬃcient amounts of procaspase-3 and
the activating enzyme system except cytochrome c. Caspase-3
activity in the S-100 increased following the addition of cyto-
chrome c, as shown in Fig. 2. The 70% of the apoptosis unit
was inhibited by EGCG at a concentration of 1 · 105 M.
The strengths of suppression by the various catechin deriva-
tives were in the same order as the inhibitions of caspase-3
activity in vitro, as shown in Table 1.
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Fig. 2. Inhibition of caspase-3 activities in apoptotic test using cultured HeLa cells induced by cytochrome c by EGCG. Caspase-3 inhibition in S-100
of cultured HeLa cells by various catechin derivatives was assayed using Nguyen and Wells’ apoptosis test as shown in Table 1, right panel [12]. The
inhibitory activities by various catechin derivatives are compared as 50% inhibition concentrations as shown in Table 1, in left panel. The catechin
derivatives added were expressed as the ﬁnal concentrations in the S-100 fraction. All data are the means ± S.E.M. (n = 5) with *P < 0.01.
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its prevention by EGCG in vivo
Suﬃcient amounts of procaspase-3 are present and active
caspase-3 is not present in the normal hepatocyte cytoplasm.
However, procaspase-3 in the cytoplasm is activated to form
active caspase-3 by the eﬀective apoptotic signal. It is well
known within the pathological ﬁeld that hepatocyte injury in-
duced by D-galactosamine results in hepatocyte apoptosis, as
assessed by the TUNNEL-staining and the DNA ladder for-
mation [3,4,10].
(1) Elevations of liver caspase-3 activity and serum amino-
transferases in D-galactosamine induced hepatocyte apop-
tosis, but were prevented by cotreatment with EGCG, as
shown in Table 2. The both elevations were prevented by
cotreatment with EGCG in a dose-dependent manner,
and treatments with 50 mg/head EGCG suppressed the
activity to the normal level. Furthermore, the macro-
scopic liver proﬁle was protected and resembled to normal
level.
However, the mechanism of procaspase-3 activation cascade
induced by D-galactosamine remains unknown (see Section 4).Table 2
Elevation of caspase-3 activities in rat liver cytoplasm in vivo and the a
administration, and the preventions by EGCG treatment in vivo
Caspase-3 activities in liver (A
Control LPS <100
D-GalN 1000.0
D-GalN + LPS 5500.0
D-GalN + LPS + EGCG 10 mg 3500.0
D-GalN + LPS + EGCG 30 mg 300.0
D-GalN + LPS + EGCG 50 mg 100.0
0.5 g/kg D-galactosamine with 50 lg/kg LPS was administered once intraper
rations of the liver cytoplasm for the caspase-3 assay are described in Section
activities in the liver cytoplasm in D-galactosamine-induced apoptosis and t
suppressions of caspase-3 activities by EGCG administration are represented
*P < 0.01.(2) TUNNEL-staining method, which is the most established
DNA nick formation in the nucleus, was examined in
these livers. As shown in Fig. 3, the signiﬁcant nick stain-
ing of nuclear DNA was observed in the livers treated
with D-galactosamine, while nick formations was signiﬁ-
cantly suppressed by cotreatment with EGCG. These data
show that D-galactosamine induced liver injury resulted in
caspase-3 mediated apoptosis and the apoptosis was sig-
niﬁcantly suppressed by EGCG administration.
(3) Increased activities of AST and ALT in the serum by D-
galactosamine administration, which are the established
marker for hepatocyte injury, were also completely sup-
pressed by cotreatment with EGCG dose-dependently as
shown in Table 2. EGCG showed an eﬀective protecting
eﬀect for the liver injury mediated by caspase-3.4. Discussion
There are several papers on cancer prevention by tea-
catechin derivatives, which appear to contradict our own data.ctivities of AST and ALT in the serum following D-galactosamine
FC nM/mg/h) Aminotransferases in serum (IU/l)
AST ALT
<37.8 <5.8
450.0 300.0
5229.3 1438.3
– –
320.5 114.0
<100 <100
itoneally. The D-galactosamine administration method and the prepa-
2.2. The injection doses of EGCG are mg/head. Elevation of caspase-3
he preventions by EGCG are in the left columns. The dose-dependent
in the left columns. All data represent the means ± S.E.M. (n = 5) with
Fig. 3. Hepatocyte apoptosis images using TUNNEL-staining induced by D-galactosamine plus LPS and its prevention by EGCG cotreatment. The
staining method is described in Section 2.2. These images are 400· magniﬁcation. Top image shows the control liver, the middle image shows liver
administrated D-galactosamine plus LPS and the suppression proﬁle by EGCG is shown in the bottom image.
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following reasons; the reported eﬀective concentration of cate-
chin for cancer prevention is very high 103–104 M [13], these
concentrations are not physiological and appear to be toxic
concentration. On the other hand, inhibition of caspase-3 by
catechins was 106–107 M in vitro and in vivo. Furthermore,
these papers do not mention on the relationship between can-
cer cell death and apoptosis mediated by caspases [13–15].
Some papers reported that catechin stimulates release of
TNF-a and enhances eﬀect of anticancer drugs in vivo. While
there is data demonstrating the prevention of oncogenesis
in vivo, there is no research at the molecular level [14,15].
There are two possible mechanisms by which catechin sup-
presses hepatocyte apoptosis induced by D-galactosamine
administration. One is due to direct inhibition of caspase-3
activity and the other is due to elimination of O2 , which is pro-duced by D-galactosamine-protein binding through Maillard
reaction. Both mechanisms are likely.
Caspase-3 is constructed from a heterotetramer, which is
composed of two pairs of heterodimers. Each unit is composed
of a long chain and a short chain. The substrate-binding site is
located in the long chains. The interaction between the long
chain and short chain and also the unit-to-unit interactions
are susceptible to allosteric eﬀectors. For example, it has been
reported by Hardy et al. [11] using synthetic allosteric inhibi-
tors that the inhibitor-binding site of the caspase-3 molecule
is diﬀerent from the substrate binding site. They also reported
that the –SH of these inhibitors can form a disulﬁde bond with
the cysteine-SH at amino acid 290th of the enzyme, which is
diﬀerent from the active site cysteine in the long chain. The
practical conformational change by EGCG will be made clear
using X-ray co-crystallography.
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